Modera Wealth Management, LLC Avadel Pharmaceuticals PLC Transaction History

Modera Wealth Management, LLC

  • $7.79 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$12.55 - $17.22 $25,815 - $35,421
2,057 Added 0.34%
600,449 $10.1 Million
Q4 2023

Feb 14, 2024
BUY
$9.64 - $14.59 $42,338 - $64,079
4,392 Added 0.74%
598,392 $8.45 Million
Q4 2022

Feb 07, 2023
BUY
$5.02 - $10.0 $240,959 - $480,000
48,000 Added 8.79%
594,000 $4.25 Million
Q3 2022

Nov 01, 2022
BUY
$2.57 - $7.31 $316,110 - $899,130
123,000 Added 29.08%
546,000 $2.74 Million
Q2 2022

Jul 27, 2022
BUY
$1.07 - $6.95 $452,610 - $2.94 Million
423,000 New
423,000 $1.03 Million

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $650M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Modera Wealth Management, LLC Portfolio

Follow Modera Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Modera Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modera Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email